Jon R. Levine - Apr 27, 2023 Form 4 Insider Report for MARIMED INC. (MRMD)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Jon R. Levine
Stock symbol: MRMD
Transactions as of: Apr 27, 2023
Transactions value $: -$18,611
Form type: 4
Date filed: 5/1/2023, 07:59 PM
Previous filing: Mar 14, 2023
Next filing: Oct 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRMD	Common stock	Options Exercise		+139K	+0.69%		20.2M	Apr 27, 2023	Direct	F1
transaction	MRMD	Common stock	Sale	-$18.6K	-49.4K	-0.25%	$0.38	20.1M	Apr 28, 2023	Direct	F2
holding	MRMD	Common stock						6.68M	Apr 27, 2023	By the Jon Levine Family Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRMD	Restricted Stock Units (RSU)	Options Exercise	$0	-139K	-16.67%	$0.00	694K	Apr 27, 2023	Common Stock, par value $.001 per share	139K		Direct	F1, F4
holding	MRMD	Restricted Stock Units (RSU)						140K	Apr 27, 2023	Common Stock, par value $.001 per share	140K		Direct	F1, F5
holding	MRMD	Option to buy common stock						5M	Apr 27, 2023	Common Stock, par value $.001 per share	5M	$0.90	Direct	F6
holding	MRMD	Option to buy common stock						5M	Apr 27, 2023	Common Stock, par value $.001 per share	5M	$0.88	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	RSUs convert to common stock on a one-for-one basis.
F2	Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the RSUs.
F3	The shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4	The RSUs vest over a three year period in equal one-sixth installments every sis months following the October 27, 2022 grant date, in accordance with the terms of an award agreement, between the Issuer and the Reporting Person.
F5	The RSUs vest over a three year period of which 46,667 RSUs will vest on March 7, 2024 and thereafter, 23,333 RSUs will vest every succeeding six (6) months through March 7, 2026, on each of September 7 and March 7, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
F6	Immediately